Skip to main content

Table 1 Respondent characteristics

From: Preemptive pharmacogenetic testing to guide chemotherapy dosing in patients with gastrointestinal malignancies: a qualitative study of barriers to implementation

Characteristic

Frequency (%)

Number of respondents

25

Role

 Medical oncologist

16 (64%)

 Oncology pharmacist

9 (36%)

 Mean age, years (range)

41.2 (28–67)

Sex

 Male

11 (44%)

 Female

14 (56%)

Race

 Non-Hispanic White

18 (72%)

 Asian

7 (28%)

 Mean time in practice, years (range) a

10.2 (0.5–35)

Comfort with interpreting PGx test results

 Comfortable or very comfortable

15 (60%)

 Neutral

3 (12%)

 Uncomfortable or very uncomfortable

7 (28%)

Comfort with using PGx test results to guide chemotherapy dosing

 Comfortable or very comfortable

14 (56%)

 Neutral

4 (16%)

 Uncomfortable or very uncomfortable

7 (28%)

 Mean interview duration, minutes (range)

30.3 (23–41)

Interview modality

 In-person

14 (56%)

 Telephone

11 (44%)